HK1 and non-small cell lung carcinoma: About glucose metabolism in cancer cells, metformin could decrease 18F-fluorodeoxyglycose uptake by directly inhibiting enzymatic activity of HKII and HKI and mimicking G6P in human non-small cell lung cancer cells33.